Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study | PLOS ONE
![Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020) Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020)](https://ec.bioscientifica.com/view/journals/ec/9/2/images/EC-19-0559equ1.jpeg)
Lipid accumulation product independently correlate with hepatic steatosis quantified by controlled attenuation parameter in women with polycystic ovary syndrome in: Endocrine Connections Volume 9 Issue 2 (2020)
![How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/ef306ace42db03995f659a9d2bbe66b9e3c84cc7/3-Table1-1.png)
How can we predict steatosis using biochemical markers (SteatoTest and Fatty liver index) | Semantic Scholar
![Table 2 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar Table 2 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c09d483d7e3b5859fb9184338691134c5092a766/23-Table2-1.png)
Table 2 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar
![PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes](https://www.researchgate.net/profile/Jelizaveta-Sokolovska/publication/316651256/figure/tbl1/AS:613447830102063@1523268768764/Correlation-R-of-factors-associated-with-liver-intrahepatic-fat-content-fatty-liver_Q320.jpg)
PDF) Fatty liver index and hepatic steatosis index predict non-alcoholic fatty liver disease in type 1 diabetes: hepatic steatosis indices for NAFLD prediction in type 1 diabetes
Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men:
![Odds ratio for fatty liver disease (fatty liver index ≥60) among the... | Download Scientific Diagram Odds ratio for fatty liver disease (fatty liver index ≥60) among the... | Download Scientific Diagram](https://www.researchgate.net/publication/256292235/figure/tbl4/AS:214328943878149@1428111410855/Odds-ratio-for-fatty-liver-disease-fatty-liver-index-60-among-the-quartiles-of.png)
Odds ratio for fatty liver disease (fatty liver index ≥60) among the... | Download Scientific Diagram
![Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease](https://f6publishing.blob.core.windows.net/bc908986-97bf-4103-ac40-6d1ff9075951/WJG-27-959-g001.png)
Ursodeoxycholic acid as a means of preventing atherosclerosis, steatosis and liver fibrosis in patients with nonalcoholic fatty liver disease
![Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches](https://pub.mdpi-res.com/diagnostics/diagnostics-12-00407/article_deploy/html/images/diagnostics-12-00407-g001.png?1644571167)
Diagnostics | Free Full-Text | Diagnostic Modalities of Non-Alcoholic Fatty Liver Disease: From Biochemical Biomarkers to Multi-Omics Non-Invasive Approaches
![Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S2387020619303110-gr1.jpg)
Recommendations for the detection, diagnosis and follow-up of patients with non-alcoholic fatty liver disease in primary and hospital care - ScienceDirect
![The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fs41598-021-93435-x/MediaObjects/41598_2021_93435_Fig2_HTML.png)
The FibroScan-aspartate aminotransferase score can stratify the disease severity in a Japanese cohort with fatty liver diseases | Scientific Reports
![Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/917304/917304_Thumb_400.jpg)
Frontiers | Nomogram for Quantitatively Estimating the Risk of Fibrosis Progression in Type 2 Diabetic Patients With Nonalcoholic Fatty Liver Disease: A Pilot Study
![Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology](https://www.thelancet.com/cms/asset/87d9133c-bb15-4be6-978a-e81c4d494678/gr1.jpg)
Health-care provision and policy for non-alcoholic fatty liver disease in sub-Saharan Africa - The Lancet Gastroenterology & Hepatology
![Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/c09d483d7e3b5859fb9184338691134c5092a766/22-Table1-1.png)
Table 1 from AST to Platelet Ratio Index and fibrosis 4 calculator scores for non-invasive assessment of hepatic fibrosis in patients with non-alcoholic fatty liver disease. | Semantic Scholar
![Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study](https://www.frontiersin.org/files/MyHome%20Article%20Library/599339/599339_Thumb_400.jpg)
Frontiers | Association Between 10-Year Fracture Probability and Nonalcoholic Fatty Liver Disease With or Without Sarcopenia in Korean Men: A Nationwide Population-Based Cross-Sectional Study
![Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD Links To And Excerpts From "Current guidelines for the management of non-alcoholic fatty liver disease: A systematic review with comparative analysis" - Tom Wade MD](https://tomwademd.net/wp-content/uploads/2022/05/fig1-7.png)